摘要
目的探讨糖皮质激素治疗儿童难治性支原体肺炎的临床效果。方法选取儿童难治性支原体肺炎患儿120例。按照就诊顺序分为研究组(甲泼尼龙琥珀酸钠)与对照组(常规药物治疗)。对比2组治疗效果。结果研究组治疗总有效率显著高于对照组(P<0.05);研究组患儿住院时间、体温恢复正常时间、咳嗽消失时间、肺部啰音消失时间显著短于对照组(P<0.05)。研究组肺外并发症发生率显著低于对照组(P<0.05)。结论采用甲泼尼龙琥珀酸钠治疗儿童难治性支原体肺炎患儿的疗效确切。
Objective To investigate the clinical effect of glucocorticoid on refractory mycoplasma pneumonia in children.Methods A total of 120 children with refractory mycoplasma pneumonia were selected,and were divided into study group treated by methylprednisolone sodium succinate and control group with conventional drug treatment according to the order of treatment.Treatment efficacy of two groups were compared.Results The study group had higher total effective rate,shorter hospitalization time,body temperature recovery time,cough disappearance time and pulmonary rales disappearance time,and lower incidence of extra-pulmonary complications than that in the control group(P<0.05).Conclusion Methylprednisolone sodium succinate in children with refractory mycoplasma pneumonia has accurate efficacy.
作者
常宇娟
CHANG Yujuan(Department of Pediatrics,Liangxiang Hospital in Fangshan District,Beijing,102400)
出处
《实用临床医药杂志》
CAS
2018年第3期117-119,共3页
Journal of Clinical Medicine in Practice
关键词
难治性支原体肺炎
糖皮质激素
甲泼尼龙
refractory mycoplasma pneumonia
glucocorticoid
methylprednisolone
